Peter Attia· MD
I think the evidence is strong enough that I take it / recommend it.
Verbal pushback — no audited source on record.
90
Loading…
The evidence is convergent. Multiple independent sources reach the same conclusion, the underlying mechanism is well-characterized, and even the field's most cautious voices treat it as worth doing.
I think the evidence is strong enough that I take it / recommend it.
Every Sunday: the week’s new conflicts and verdict changes — and nothing else.
Native comments, Twitter mentions, and Reddit threads about this claim — surfaced together so the conversation isn't fragmented across platforms.
Bookmarking — the dossier-vs-overview split is the right call. Most of the time I want overview; sometimes I want receipts.
Would love a "what would change this verdict" RSS feed. Sign me up if it exists.
I think the evidence is strong enough that I take it / recommend it.
GLP-1 agonists in non-diabetic adults with BMI < 30 produce more harm than benefit on a population basis.
GLP-1 agonists in non-obese adults cause clinically significant muscle and bone loss without resistance training.